文献速递头颈部肿瘤放疗

接受调强放疗期间自适应再计划的鼻咽癌患者靶区缩减后局部区域复发失败模式:中国单中心经验

Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
PubMed 文献 · Radiat Oncol · 2023-11-16

本研究纳入2011年8月至2018年4月在本院接受调强放疗的274例初诊非转移性鼻咽癌患者,其中174例接受自适应再计划、100例未接受。再计划组5年局部区域无复发生存率为90.1%,未再计划组为80.8%(P=0.045);复发以高剂量区内野内失败为主,再计划组1例(5.9%)为野外失败、16例(94.1%)为野内失败,未再计划组1例(5.3%)为野外、2例(10.5%)为边缘、16例(84.2%)为野内失败。作者认为自适应再计划缩减靶区可行,未导致缩减区域额外复发。

要点

  • 再计划组5年局部区域无复发生存率90.1%,未再计划组80.8%,P=0.045。
  • 再计划组17次复发中16次(94.1%)为野内失败,1次(5.9%)为野外失败。
  • 未再计划组19例复发中16例(84.2%)野内、2例(10.5%)边缘、1例(5.3%)野外。

核心结论

  • 高剂量区内野内失败是非转移性鼻咽癌最常见的局部区域复发模式。
  • 调强放疗期间自适应调整靶区并修改肿瘤缩减区域处方剂量是可行的,且不会导致缩减区域额外复发。

研究设计与样本

  • 本研究为单中心经验,连续纳入2011年8月至2018年4月在本院接受调强放疗的鼻咽癌患者。
  • 入组条件为初诊、组织学确诊、无转移的鼻咽癌,共274例;100例(36.5%)接受调强放疗未再计划,174例(63.5%)接受调强放疗联合再计划。
  • 将局部区域复发的位置和范围转移至放疗前计划CT进行剂量学分析。

主要发现

  • 再计划组5年局部区域无复发生存率为90.1%(95%CI 84.8%至95.4%),未再计划组为80.8%(95%CI 72.0%至89.6%),P=0.045。
  • 再计划组15例患者共发生17次局部区域复发,其中野内失败16次(94.1%)、野外失败1次(5.9%)。
  • 未再计划组19例患者发生局部区域复发,其中野内失败16例(84.2%)、边缘失败2例(10.5%)、野外失败1例(5.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous researches have demonstrated that adaptive replanning during intensity-modulated radiation therapy (IMRT) could enhance the prognosis of patients with nasopharyngeal carcinoma (NPC). However, the delineation of replanning target volumes remains unclear. This study aimed to evaluate the feasibility of reducing target volumes through adaptive replanning during IMRT by analyzing long-term survival outcomes and failure patterns of locoregional recurrence in NPC. METHODS: This study enrolled consecutive NPC patients who received IMRT at our hospital between August 2011 and April 2018. Patients with initially diagnosed, histologically verified, non-metastatic nasopharyngeal cancer were eligible for participation in this study. The location and extent of locoregional recurrences were transferred to pretreatment planning computed tomography for dosimetry analysis. RESULTS: Among 274 patients, 100 (36.5%) received IMRT without replanning and 174 (63.5%) received IMRT with replanning. Five-year rates of locoregional recurrence-free survival (LRFS) were 90.1% (95%CI, 84.8% to 95.4%) and 80.8% (95%CI, 72.0% to 89.6%) for patients with and without replanning, P = 0.045. There were 17 locoregional recurrences in 15 patients among patients with replanning, of which 1 (5.9%) was out-field and 16 (94.1%) were in-field. Among patients without replanning, 19 patients developed locoregional recurrences, of which 1 (5.3%) was out-field, 2 (10.5%) were marginal, and 16 (84.2%) were in-field. CONCLUSIONS: In-field failure inside the high dose area was the most common locoregional recurrent pattern for non-metastatic NPC. Adapting the target volumes and modifying the radiation dose prescribed to the area of tumor reduction during IMRT was feasible and would not cause additional recurrence in the shrunken area.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zhou X, Zhu J, Zhou C, et al. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China. Radiat Oncol. 2023. PMID: 37974274. doi:10.1186/s13014-023-02373-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。